Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-B7-H3 Antibody-FITC (7G630) (Synonyms: CD276 molecule, B7RP-2, B7-H3, B7H3, 4Ig-B7-H3)

Catalog No. TMAY-01732F Copy Product Info
🥰Excellent
Anti-B7-H3 Antibody-FITC (7G630) is a FITC-conjugated Mouse antibody targeting B7-H3. Anti-B7-H3 Antibody-FITC (7G630) can be used in FCM.

Anti-B7-H3 Antibody-FITC (7G630)

Copy Product Info
🥰Excellent
Catalog No. TMAY-01732F
Synonyms CD276 molecule, B7RP-2, B7-H3, B7H3, 4Ig-B7-H3

Anti-B7-H3 Antibody-FITC (7G630) is a FITC-conjugated Mouse antibody targeting B7-H3. Anti-B7-H3 Antibody-FITC (7G630) can be used in FCM.

Anti-B7-H3 Antibody-FITC
(7G630)
Pack SizePriceUSA StockGlobal StockQuantity
25 T$827-10 days7-10 days
100 T$2587-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-B7-H3 Antibody-FITC (7G630) is a FITC-conjugated Mouse antibody targeting B7-H3. Anti-B7-H3 Antibody-FITC (7G630) can be used in FCM.
SynonymsCD276 molecule, B7RP-2, B7-H3, B7H3, 4Ig-B7-H3
Ig Type
Mouse IgG2b
Clone
7G630
Reactivity
Human
Specificity
Human B7-H3
Verified Activity
Flow cytometric analysis of anti-B7H3 (CD276) reactivity on PC-3 cells.
Application
Recommended Dose
10 μl/Test, 0.1 mg/ml
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human B7-H3 / CD276 (rh B7-H3 / CD276; TMPY-02031; Q5ZPR3-1; Met 1-Thr 461) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
PurificationProtein A
AppearanceLiquid
FormulationPBS solution containing 0.5% BSA and 0.03%ProClin300
Research BackgroundB7-H3 is a member of the B7 family of immune regulatory ligands that is thought to attenuate peripheral immune responses through co-inhibition. It plays an important role in adaptive immune responses, and was shown to either promote or inhibit T-cell responses in various experimental systems. B7-H3 may play an important role in muscle-immune interactions, providing further evidence of the active role of muscle cells in local immunoregulatory processes. B7-H3 is a novel protein structurally related to the B7 family of ligands by the presence of a single set of immunoglobulin-V-like and immunoglobulin-C-like (VC) domains. Previous studies have correlated its overexpression with poor prognosis and decreased tumor-infiltrating lymphocytes in various carcinomas including uterine endometrioid carcinomas, and mounting evidence supports an immuno-inhibitory role in ovarian cancer prognosis. Recently, B7-H3 expression has been reported in several human cancers indicating an additional function of B7-H3 as a regulator of antitumor immunity.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: ICC AntibodiesImmune Checkpoint Detection: IP AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint TargetsImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
FITC
Others Formats
Unconjugated/APC/HRP/PE
Antibody Types Available
5
Antigen Details
Immunogen
Recombinant Protein: Human B7-H3 / CD276 protein (TMPY-02031)
Antigen Species
Human
Biology Area
Cancer Drug Targets
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Anti-B7-H3 Antibody-FITC (7G630) | purchase Anti-B7-H3 Antibody-FITC (7G630) | Anti-B7-H3 Antibody-FITC (7G630) cost | order Anti-B7-H3 Antibody-FITC (7G630)